| Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure LM Kucirka, SA Lauer, O Laeyendecker, D Boon, J Lessler Annals of internal medicine 173 (4), 262-267, 2020 | 1753 | 2020 |
| Chimpanzees as an animal model for human norovirus infection and vaccine development K Bok, GI Parra, T Mitra, E Abente, CK Shaver, D Boon, R Engle, C Yu, ... Proceedings of the National Academy of Sciences 108 (1), 325-330, 2011 | 273 | 2011 |
| Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, ... Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 02257-20, 2021 | 207 | 2021 |
| Comparative evolution of GII. 3 and GII. 4 norovirus over a 31-year period D Boon, JE Mahar, EJ Abente, CD Kirkwood, RH Purcell, AZ Kapikian, ... Journal of virology 85 (17), 8656-8666, 2011 | 175 | 2011 |
| Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011–2016 EU Patel, CL Thio, D Boon, DL Thomas, AAR Tobian Clinical Infectious Diseases 69 (4), 709-712, 2019 | 163 | 2019 |
| B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure P Farci, G Diaz, Z Chen, S Govindarajan, A Tice, L Agulto, S Pittaluga, ... Proceedings of the National Academy of Sciences 107 (19), 8766-8771, 2010 | 151 | 2010 |
| Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences C Yu, D Boon, SL McDonald, TG Myers, K Tomioka, H Nguyen, RE Engle, ... Journal of virology 84 (21), 11264-11278, 2010 | 106 | 2010 |
| Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda D Boon, AD Redd, O Laeyendecker, RE Engle, H Nguyen, P Ocama, ... The Journal of infectious diseases 217 (5), 785-789, 2018 | 22 | 2018 |
| Limited coverage of hepatitis C virus testing in the United States, 2013–2017 EU Patel, SH Mehta, D Boon, TC Quinn, DL Thomas, AAR Tobian Clinical Infectious Diseases 68 (8), 1402-1405, 2019 | 19 | 2019 |
| Use of hepatitis C virus (HCV) immunoglobulin G antibody avidity as a biomarker to estimate the population-level incidence of HCV infection EU Patel, AL Cox, SH Mehta, D Boon, CE Mullis, J Astemborski, ... The Journal of infectious diseases 214 (3), 344-352, 2016 | 18 | 2016 |
| Antibody avidity-based approach to estimate population-level incidence of hepatitis C D Boon, V Bruce, EU Patel, J Quinn, AK Srikrishnan, S Shanmugam, ... Journal of hepatology 73 (2), 294-302, 2020 | 8 | 2020 |
| Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India SS Solomon, D Boon, S Saravanan, AK Srikrishnan, CK Vasudevan, ... Virusdisease 30, 490-497, 2019 | 7 | 2019 |
| Perspectives on recent reviews of aspartame cancer epidemiology JE Goodman, DN Boon, MM Jack Global Epidemiology 6, 100117, 2023 | 4 | 2023 |
| The role of study quality in aspartame and cancer epidemiology study reviews JE Goodman, EG Anneser, A Khandaker, DN Boon Global Epidemiology 5, 100110, 2023 | 3 | 2023 |
| Research on COVID-19 and air pollution: A path towards advancing exposure science CJ Burns, JS LaKind, J Naiman, D Boon, JE Clougherty, AM Rule, A Zidek Environmental research 212, 113240, 2022 | 3 | 2022 |
| Nickel in ambient particulate matter and respiratory or cardiovascular outcomes: A critical review W Li, J Zhou, D Boon, T Fan, E Anneser, JE Goodman, RL Prueitt Environmental Pollution, 123442, 2024 | 2 | 2024 |
| Trends in heroin use and injection drug use among high school students in five urban school districts in the US (2005–2017) RM Johnson, D Boon, X Wang, LB Beach, SC Brighthaupt, KE Schneider, ... Journal of ethnicity in substance abuse 22 (4), 681-687, 2023 | 2 | 2023 |
| Considerations towards the better integration of epidemiology into quantitative risk assessment SE Déglin, I Burstyn, CL Chen, DJ Miller, MO Gribble, AK Hamade, ... Global Epidemiology 4, 100084, 2022 | 2 | 2022 |
| Curating the evidence about COVID-19 for frontline public health and clinical care: the novel coronavirus research compendium AD Redd, LS Peetluk, BA Jarrett, C Hanrahan, S Schwartz, A Rao, ... Public Health Reports 137 (2), 197-202, 2022 | 2 | 2022 |
| Hepatitis C IgG antibody avidity as a biomarker to estimate population-level incidence EU Patel, AL Cox, SH Mehta, D Boon, C Mullis, J Astemborski, ... Journal of Infectious Diseases, 2016 | 2 | 2016 |